Former FDA Commissioner Scott Gottlieb, who serves on the board of Pfizer, expressed alarm over the CDC's decision to delay the Hepatitis B dose. He argued that the advisory committee (ACIP) is being degraded by "anti-vax activists" and that its decisions will no longer be respected by states or insurers. Gottlieb emphasized the risks of chronic infection in children under five, while the hosts suggest the shift is a necessary move toward informed consent and removing pharma indemnification.



















